US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist

30.810
+1.840+6.35%

Close May 22 16:00 ET

2.05BMarket Cap-28396P/E (TTM)

CG Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

172.68%529K

6.81%204K

194K

-98.16%191K

10.36M

Operating revenue

172.68%529K

6.81%204K

--1K

--194K

-98.16%191K

--0

--10.36M

Cost of revenue

Gross profit

Operating expense

131.95%23M

57.05%55.65M

103.25%18.93M

9.92M

54.32%35.44M

9.32M

22.96M

Selling and administrative expenses

179.21%5.79M

54.51%9.9M

82.14%3.02M

--2.07M

37.95%6.41M

--1.66M

--4.65M

-General and administrative expense

179.21%5.79M

54.51%9.9M

82.14%3.02M

--2.07M

37.95%6.41M

--1.66M

--4.65M

Research and development costs

119.46%17.21M

57.61%45.75M

107.82%15.92M

--7.84M

58.46%29.03M

--7.66M

--18.32M

Operating profit

-131.14%-22.47M

-57.32%-55.45M

-103.24%-18.93M

-9.72M

-179.60%-35.25M

-9.32M

-12.61M

Net non-operating interest income expense

430.21%5.55M

690,500.00%6.9M

209.89%2.82M

1.05M

99.78%-1K

910K

-451K

Non-operating interest income

430.21%5.55M

----

--1.05M

----

Non-operating interest expense

----

--451K

Total other finance cost

----

-690,500.00%-6.9M

-209.89%-2.82M

----

--1K

---910K

----

Other net income (expense)

-212.50%-9K

68.37%-62K

-130.77%-4K

-189.91%-196K

13K

218K

Other non- operating income (expenses)

-212.50%-9K

68.37%-62K

-130.77%-4K

--8K

-189.91%-196K

--13K

--218K

Income before tax

-95.36%-16.93M

-37.14%-48.61M

-92.04%-16.12M

-8.67M

-176.06%-35.44M

-8.39M

-12.84M

Income tax

Net income

-95.36%-16.93M

-37.14%-48.61M

-92.04%-16.12M

-8.67M

-176.06%-35.44M

-8.39M

-12.84M

Net income continuous Operations

-95.36%-16.93M

-37.14%-48.61M

-92.04%-16.12M

---8.67M

-176.06%-35.44M

---8.39M

---12.84M

Minority interest income

Net income attributable to the parent company

-95.36%-16.93M

-37.14%-48.61M

-92.04%-16.12M

-8.67M

-176.06%-35.44M

-8.39M

-12.84M

Preferred stock dividends

129.97%19.19M

57.43%5.94M

3.73M

50.52%8.35M

3.77M

5.54M

Other preferred stock dividends

Net income attributable to common stockholders

-36.54%-16.93M

-54.83%-67.8M

-81.31%-22.05M

-12.4M

-138.20%-43.79M

-12.16M

-18.38M

Basic earnings per share

87.43%-0.36

-33.65%-15.65

87.63%-0.3474

-2.8634

-2,046.69%-11.71

-2.8082

-0.5455

Diluted earnings per share

87.43%-0.36

-33.65%-15.65

87.63%-0.3474

-2.8634

-2,046.69%-11.71

-2.8082

-0.5455

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	172.68%529K	6.81%204K	1K	194K	-98.16%191K	0	10.36M
Operating revenue	172.68%529K	6.81%204K	--1K	--194K	-98.16%191K	--0	--10.36M
Cost of revenue
Gross profit
Operating expense	131.95%23M	57.05%55.65M	103.25%18.93M	9.92M	54.32%35.44M	9.32M	22.96M
Selling and administrative expenses	179.21%5.79M	54.51%9.9M	82.14%3.02M	--2.07M	37.95%6.41M	--1.66M	--4.65M
-General and administrative expense	179.21%5.79M	54.51%9.9M	82.14%3.02M	--2.07M	37.95%6.41M	--1.66M	--4.65M
Research and development costs	119.46%17.21M	57.61%45.75M	107.82%15.92M	--7.84M	58.46%29.03M	--7.66M	--18.32M
Operating profit	-131.14%-22.47M	-57.32%-55.45M	-103.24%-18.93M	-9.72M	-179.60%-35.25M	-9.32M	-12.61M
Net non-operating interest income expense	430.21%5.55M	690,500.00%6.9M	209.89%2.82M	1.05M	99.78%-1K	910K	-451K
Non-operating interest income	430.21%5.55M	----	----	--1.05M	----	----	----
Non-operating interest expense	----	----	----	----	----	----	--451K
Total other finance cost	----	-690,500.00%-6.9M	-209.89%-2.82M	----	--1K	---910K	----
Other net income (expense)	-212.50%-9K	68.37%-62K	-130.77%-4K	8K	-189.91%-196K	13K	218K
Other non- operating income (expenses)	-212.50%-9K	68.37%-62K	-130.77%-4K	--8K	-189.91%-196K	--13K	--218K
Income before tax	-95.36%-16.93M	-37.14%-48.61M	-92.04%-16.12M	-8.67M	-176.06%-35.44M	-8.39M	-12.84M
Income tax
Net income	-95.36%-16.93M	-37.14%-48.61M	-92.04%-16.12M	-8.67M	-176.06%-35.44M	-8.39M	-12.84M
Net income continuous Operations	-95.36%-16.93M	-37.14%-48.61M	-92.04%-16.12M	---8.67M	-176.06%-35.44M	---8.39M	---12.84M
Minority interest income
Net income attributable to the parent company	-95.36%-16.93M	-37.14%-48.61M	-92.04%-16.12M	-8.67M	-176.06%-35.44M	-8.39M	-12.84M
Preferred stock dividends		129.97%19.19M	57.43%5.94M	3.73M	50.52%8.35M	3.77M	5.54M
Other preferred stock dividends
Net income attributable to common stockholders	-36.54%-16.93M	-54.83%-67.8M	-81.31%-22.05M	-12.4M	-138.20%-43.79M	-12.16M	-18.38M
Basic earnings per share	87.43%-0.36	-33.65%-15.65	87.63%-0.3474	-2.8634	-2,046.69%-11.71	-2.8082	-0.5455
Diluted earnings per share	87.43%-0.36	-33.65%-15.65	87.63%-0.3474	-2.8634	-2,046.69%-11.71	-2.8082	-0.5455
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall